Human cartilage glycoprotein 39-biomarker of joint damage in knee osteoarthritis

被引:40
作者
Zivanovic, Sandra [1 ]
Rackov, Ljiljana Petrovic [2 ]
Vojvodic, Danilo [3 ]
Vucetic, Dusan [4 ]
机构
[1] Hlth Ctr Kragujevac, Kragujevac, Serbia
[2] Mil Med Acad, Clin Rheumatol & Clin Immunol, Belgrade 11002, Serbia
[3] Mil Med Acad, Inst Med Res, Belgrade 11002, Serbia
[4] Mil Med Acad, Inst Transfusiol, Belgrade 11002, Serbia
关键词
RHEUMATOID-ARTHRITIS; BIOCHEMICAL MARKERS; ARTICULAR CHONDROCYTES; SYNOVIAL-FLUID; SERUM YKL-40; BONE; ULTRASONOGRAPHY; LOCALIZATION; PROTEIN; DISEASE;
D O I
10.1007/s00264-009-0747-8
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Human glycoprotein of cartilage (YKL-40) synthesises chondrocytes and synovial cells in inflammatory conditions or remodels the outer cell matrix in osteoarthritis. The aim of this study was to conduct a parallel analysis between thickness of cartilage and length of osteophytes, ultrasound indicators of joint destruction, with levels of YKL-40 in serum in patients with primary osteoarthritis. Ultrasound findings and concentration of YKL-40(ng/ml) were examined in 88 patients. The average value cartilage thickness measured on medial condyles of the femur was 1.30 +/- 0.23 mm and on lateral was 1.39 +/- 0.27 mm. Median YKL-40 in patients with shorter osteophytes was 62.0 (44.5-90) ng/ml, and with longer osteophytes was 119 (range 80-171) ng/ml (p = 0.000). YKL-40 can be a marker for the appearance of longer osteophytes (sensitivity = 79.1%; specificity = 61.9%;cut off = 75.0 ng/ml). The duration of illness is very much connected to values of YKL-40 (r = 0.651, p = 0.000). After an illness duration of five years, the concentration of YKL-40 was 83.68 +/- 33.65 ng/ml, after ten years it was 138.22 +/- 48.88 ng/ml, and after 15 and 20 years it was 209.30 +/- 79.36 ng/ml and 218.50 +/- 106.51 ng/ml, respectively. Higher concentrations of YKL-40 indicate the level of cartilage destruction and can be used for assessment of destruction.
引用
收藏
页码:1165 / 1170
页数:6
相关论文
共 21 条
  • [1] Biological mechanisms of bone and cartilage remodelling-genomic perspective
    Borovecki, F.
    Pecina-Slaus, N.
    Vukicevic, S.
    [J]. INTERNATIONAL ORTHOPAEDICS, 2007, 31 (06) : 799 - 805
  • [2] Bruyere O, 2003, J RHEUMATOL, V30, P1043
  • [3] Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study
    Conrozier, T
    Carlier, MC
    Mathieu, P
    Colson, F
    Debard, AL
    Richard, S
    Favret, H
    Bienvenu, J
    Vignon, E
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (10) : 828 - 831
  • [4] EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: Prevalence of inflammation in osteoarthritis
    D'Agostino, MA
    Conaghan, P
    Le Bars, M
    Baron, G
    Grassi, W
    Martin-Mola, E
    Wakefield, R
    Brasseur, JL
    So, A
    Backhaus, M
    Malaise, M
    Burmester, G
    Schmidely, N
    Ravaud, P
    Dougados, M
    Emery, P
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (12) : 1703 - 1709
  • [5] Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage
    Garnero, P
    Piperno, M
    Gineyts, E
    Christgau, S
    Delmas, PD
    Vignon, E
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (06) : 619 - 626
  • [6] HAKALA BE, 1993, J BIOL CHEM, V268, P25803
  • [7] Harvey S, 1998, CLIN CHEM, V44, P509
  • [8] Johansen JS, 1996, BRIT J RHEUMATOL, V35, P553
  • [9] JOHANSEN JS, 1993, BRIT J RHEUMATOL, V32, P949
  • [10] Johansen JS, 2001, ARTHRITIS RHEUM-US, V44, P826